Karolinska Development
Karolinska Development AB is a Swedish Nordic life science investment company operating in the pharmaceutical and medical technology sectors. The company identifies, finances, and develops early-stage healthcare innovations originating from universities and research institutions across the Nordic region. Revenue is generated from capital appreciation upon the sale or IPO of portfolio companies alongside licensing fees, royalties, and dividend distributions from underlying investments. Core end markets serve global pharmaceutical corporations, medical device manufacturers, clinical trial institutions, and healthcare providers. Karolinska Development holds an established market position in the Nordic venture capital sector as a specialized incubator for life science commercialization. The company is headquartered in Solna, Sweden, and its Class B shares trade on the Nasdaq Stockholm exchange.
2 of the funds FundTelligence covers report a position in Karolinska Development.
- Sector
- Financials
- Country
- Sweden
- Funds holding it
- 2
Funds holding Karolinska Development
- Storebrand Sverige Småbolag Plus — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.0 % (full portfolio disclosed, October 2026)